Payment overview · 2025
General Payments
$13.66
1 reported records · 1 companies
Healthcare provider profile · identity verified
Farid Murshed, MD
Allopathic & Osteopathic Physicians|Internal Medicine · HAGERSTOWN, MD · NPI 1366483323
Verified facts
What the public records show
CMS Open Payments records show Farid Murshed, MD received $13.66 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $13.66 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.66 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $13.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 29 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 623 | 115 |
| Gabapentin | Gabapentin | 333 | 48 |
| Levothyroxine Sodium | Levothyroxine Sodium | 277 | 59 |
| Eliquis | Apixaban | 271 | 49 |
| Amlodipine Besylate | Amlodipine Besylate | 269 | 62 |
| Furosemide | Furosemide | 243 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 241 | 58 |
| Lisinopril | Lisinopril | 223 | 49 |
| Trazodone Hcl | Trazodone Hcl | 185 | 37 |
| Omeprazole | Omeprazole | 184 | 45 |
| Xarelto | Rivaroxaban | 181 | 15 |
| Mirtazapine | Mirtazapine | 175 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 172 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 162 | 30 |
| Sertraline Hcl | Sertraline Hcl | 155 | 29 |
| Potassium Chloride | Potassium Chloride | 151 | 38 |
| Losartan Potassium | Losartan Potassium | 149 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 140 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 140 | 40 |
| Metformin Hcl | Metformin Hcl | 137 | 33 |
| Donepezil Hcl | Donepezil Hcl | 133 | 18 |
| Trulicity | Dulaglutide | 128 | 14 |
| Olanzapine | Olanzapine | 109 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 107 | 14 |
| Buspirone Hcl | Buspirone Hcl | 99 | 23 |
| Levetiracetam | Levetiracetam | 99 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 98 | 25 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 86 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 86 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 81 | 16 |
| Simvastatin | Simvastatin | 81 | 24 |
| Montelukast Sodium | Montelukast Sodium | 78 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 76 | 13 |
| Fenofibrate | Fenofibrate Nanocrystallized | 75 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 74 | 26 |
| Spironolactone | Spironolactone | 74 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 73 | 20 |
| Allopurinol | Allopurinol | 63 | 17 |
| Enulose | Lactulose | 63 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 17 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 62 | 60 |
| Amiodarone Hcl | Amiodarone Hcl | 60 | 14 |
| Midodrine Hcl | Midodrine Hcl | 59 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 58 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 53 | suppressed |
| Cefazolin Sodium | Cefazolin Sodium | 48 | suppressed |
| Nifedipine Er | Nifedipine | 47 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 46 | 20 |
| Lactulose | Lactulose | 44 | suppressed |
| Latanoprost | Latanoprost | 44 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 42 | suppressed |
| Baclofen | Baclofen | 41 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 41 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 40 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 26 |
| Carvedilol | Carvedilol | 38 | 16 |
| Lorazepam | Lorazepam | 38 | 17 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 37 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 19 |
| Finasteride | Finasteride | 36 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 32 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 32 | 11 |
| Glipizide | Glipizide | 31 | suppressed |
| Memantine Hcl | Memantine Hcl | 31 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 31 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 30 | 15 |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 19 |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 30 | suppressed |
| Lamotrigine | Lamotrigine | 29 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Ozempic | Semaglutide | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Meloxicam | Meloxicam | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 13 |
| Famotidine | Famotidine | 27 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Repaglinide | Repaglinide | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 25 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Prednisone | Prednisone | 25 | 16 |
| Ammonium Lactate | Ammonium Lactate | 24 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Nystatin | Nystatin | 24 | suppressed |
| Clonazepam | Clonazepam | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 23 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 23 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 12 |
| Azithromycin | Azithromycin | 22 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 22 | 12 |
| Lacosamide | Lacosamide | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 17 |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 20 | 20 |
| Bumetanide | Bumetanide | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 19 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 19 | 17 |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Loperamide | Loperamide Hcl | 17 | suppressed |
| Minoxidil | Minoxidil | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 11 |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 15 | suppressed |
| Olanzapine Odt | Olanzapine | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Fluocinonide | Fluocinonide | 14 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Insulin Lispro | Insulin Lispro | 13 | suppressed |
| Lupron Depot | Leuprolide Acetate | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.66 · 1 records | Novo Nordisk Inc | Ozempic | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error